Our operational excellence continues to be a cornerstone of our
success. Our financial fundamentals and the market's confidence in our growth
prospects are well acknowledged through a robust credit rating and significantly improved
market capitalization.
Dear Shareholders,
Your company demonstrated its unwavering commitment to growth,
innovation and operational excellence, despite a complex and dynamic global business
landscape.
FY 2024-25 marked the sixth consecutive year of growth in both revenue
and profitability – a strong endorsement of our robust business model and the
successful execution of our transformation strategy.
Our strategic pivot towards chronic and specialty therapies has been
particularly impactful.
Through a well-crafted strategy, robust new product grid and
disciplined execution, we introduced several new products across all three of our business
segments, positioning us well for sustained growth.
Our operational excellence continues to be a cornerstone of our
success. Our financial fundamentals and the market's confidence in our growth
prospects are well acknowledged through a robust credit rating and significantly improved
market capitalization.
While FY 2024-25 was a year of achievements, it was also one of
heightened global uncertainties.
A slowing global economy, persistent inflation, rising interest rates,
and geopolitical tensions – particularly the threat of higher tariffs from the US
– have created headwinds for several industries, including pharmaceuticals. Our
strategy to continually diversify export markets as well as strongly focus on domestic
market, positions us well to navigate these challenges.
India, meanwhile, continues to stand out as the world's f a s t e
s t - g r o w i n g m a j o r economy, supported by stable macroeconomic conditions,
structural reforms, and resilient domestic demand. This provides us with a strong
foundation for continued expansion and long-term value creation.
Looking ahead, RPG Life
Sciences is well-prepared to build on its operational strengths and
accelerate its growth trajectory.
With a sharp focus on innovation, market expansion, and strategic
partnerships – both organic and inorganic – we remain confident in our ability
to deliver sustainable, long-term returns.
I would like to express my sincere gratitude for your trust and
support. Together, we will continue to shape a brighter and healthier future.